What advances mean for modern laboratories, and why continued innovation is imperative by Dr Gina Zini
The subtyping of bladder cancers is a complicated business. It is, however, necessary as it has important implications for prognosis and therapeutic decisions. CLI caught up with Asst. Prof. Chelsea L. Jackson (University of Manitoba, Winnipeg, MB, Canada) and Prof. David Berman (Queen’s University, Kingston, ON, Canada) to find out more about how the current […]
Bronchoalveolar lavage is an effective way of collecting samples of cells and molecules from the alveoli of the lungs, the analysis of which may allow proteomic determination of signatures of disease states and so aid diagnosis. Such analysis has, however, been hampered by a number of factors. CLI caught up with Professors Griffin and Wendt […]
Researchers from the United Kingdom hope that a new, publicly available database they have created will shrink, not grow, over time. That’s because it is a compendium of the thousands of understudied proteins encoded by genes in the human genome, whose existence is known but whose functions are mostly not.
Researchers from the Organoid group (Hubrecht Institute, Utrecht University)) and the Princess Máxima Center (Utrecht, The Netherlands) have taken steps to advance cancer tumour models by using base editors to simultaneously introduce multiple cancer-related mutations into healthy organoids. They thereby succeeded in efficiently making tumour organoids that model liver, colorectal and endometrial cancer. The results […]
Scientists have developed a synthetic extracellular matrix (ECM) that can support the growth of a mini endometrium in a dish for at least two weeks.
Scientific excellence requires diversity – research conducted by men and women, by people from different backgrounds and with varied worldviews. The need for diversity extends to scientific experiments themselves, but even today the vast majority of studies in the life sciences are done on male mice only, which could harm the findings, as well as […]
In March this year, Werfen announced that it has successfully completed the acquisition of Immucor, Inc., after obtaining all necessary regulatory and antitrust approvals. Immucor is a privately held, US-based company, in the in vitro diagnostics (IVD) sector, with a solid global presence in the Transfusion and Transplant markets.
Moving liquids in a precise and productive way is core to the work of many laboratory professionals in the life sciences industry.
Quantimetrix Corp. was set up almost 50 years ago to create clinical diagnostic test kits. CLI caught up with Monty Ban, Chairman, President and CEO, to discover more about the company and how it has developed since it started out.
January 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.